The Global Active Pharmaceutical Ingredient (API) Market is segmented on the lines of its manufacturing process, API type, therapeutic area, drug type and regional. Based on manufacturing process segmentation it covers captive, contract. Based on API type segmentation it covers synthetic chemical API, biological API. Based on therapeutic area segmentation it covers cardiovascular disorders, metabolic disorders, neurological disorders, oncology, musculoskeletal disorders, NSAIDs, other therapeutics uses. Based on drug type segmentation it covers branded prescription drugs, generic prescription drugs, OTC prescription drugs.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Allergan plc, BASF SE, Boehringer Ingelheim Group, Cambrex Corporation, Dr. Reddy’s Laboratories Ltd., Lonza Group, Mylan, Inc., Sandoz (Novartis AG), Pfizer, Inc., Teva Pharmaceutical Industries Ltd., and WuXiApptec. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
The Global Active Pharmaceutical Ingredient (API) Market is expected to exceed more than US$ 219.60 Billion by 2023 at a CAGR of 6.3% in the given forecast period.
Find Full Report @: https://www.marketresearchengine.com/active-pharmaceutical-ingredient-market
The Global Active Pharmaceutical Ingredient (API) Market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geographic market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.
Table of Contents
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Active Pharmaceutical Ingredients Market, By Type
7 Active Pharmaceutical Ingredients Market, By Type of Manufacturer
8 Active Pharmaceutical Ingredients Market, By Type of Synthesis
9 Active Pharmaceutical Ingredients Market, By Type of Drug
10 Active Pharmaceutical Ingredients Market, By Therapeutic Application
11 Active Pharmaceutical Ingredients Market, By Region
12 Competitive Landscape
13 Company Profiles
13.2 Pfizer, Inc.
13.3 Novartis International AG
13.5 Boehringer Ingelheim
13.6 Bristol-Myers Squibb
13.7 Teva Pharmaceutical Industries Ltd.
13.8 ELI Lilly and Company
13.9 Glaxosmithkline PLC
13.10 Merck & Co., Inc.
13.11 Abbvie Inc.
Company Name: Market Research Engine
Contact Person: John Bay
Country: United States
Information contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact firstname.lastname@example.org